Banks - Regional
Compare Stocks
2 / 10Stock Comparison
CHYM vs AFRM
Revenue, margins, valuation, and 5-year total return — side by side.
Software - Infrastructure
CHYM vs AFRM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Banks - Regional | Software - Infrastructure |
| Market Cap | $7.61B | $22.44B |
| Revenue (TTM) | $2.19B | $3.20B |
| Net Income (TTM) | $-969M | $382M |
| Gross Margin | 85.9% | 62.6% |
| Operating Margin | -47.6% | 10.2% |
| Forward P/E | 112.9x | 62.5x |
| Total Debt | $135M | $7.85B |
| Cash & Equiv. | $466M | $1.35B |
CHYM vs AFRM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 25 | May 26 | Return |
|---|---|---|---|
| Chime Financial, In… (CHYM) | 100 | 55.1 | -44.9% |
| Affirm Holdings, In… (AFRM) | 100 | 97.4 | -2.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CHYM vs AFRM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CHYM is the clearest fit if your priority is income & stability and sleep-well-at-night.
- beta 2.50
- Lower volatility, beta 2.50, Low D/E 9.6%, current ratio 4.53x
- Beta 2.50, current ratio 4.53x
AFRM carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 38.8%, EPS growth 109.0%, 3Y rev CAGR 33.7%
- -30.7% 10Y total return vs CHYM's -48.8%
- 38.8% revenue growth vs CHYM's 30.7%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 38.8% revenue growth vs CHYM's 30.7% | |
| Value | Lower P/E (62.5x vs 112.9x) | |
| Quality / Margins | 11.9% margin vs CHYM's -46.2% | |
| Stability / Safety | Beta 2.50 vs AFRM's 2.72, lower leverage | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | +30.7% vs CHYM's -48.8% | |
| Efficiency (ROA) | 3.1% ROA vs CHYM's -49.8%, ROIC -0.7% vs -60.2% |
CHYM vs AFRM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CHYM vs AFRM — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
AFRM leads this category, winning 3 of 4 comparable metrics.
Income & Cash Flow (Last 12 Months)
AFRM and CHYM operate at a comparable scale, with $3.2B and $2.2B in trailing revenue. AFRM is the more profitable business, keeping 11.9% of every revenue dollar as net income compared to CHYM's -46.2%.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $2.2B | $3.2B |
| EBITDAEarnings before interest/tax | -$976M | $533M |
| Net IncomeAfter-tax profit | -$969M | $382M |
| Free Cash FlowCash after capex | $144M | $787M |
| Gross MarginGross profit ÷ Revenue | +85.9% | +62.6% |
| Operating MarginEBIT ÷ Revenue | -47.6% | +10.2% |
| Net MarginNet income ÷ Revenue | -46.2% | +11.9% |
| FCF MarginFCF ÷ Revenue | +1.5% | +24.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | -65.8% |
| EPS Growth (YoY)Latest quarter vs prior year | -35.0% | — |
Valuation Metrics
AFRM leads this category, winning 3 of 5 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $7.6B | $22.4B |
| Enterprise ValueMkt cap + debt − cash | $7.3B | $28.9B |
| Trailing P/EPrice ÷ TTM EPS | -7.15x | 449.07x |
| Forward P/EPrice ÷ next-FY EPS est. | 112.89x | 62.49x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | 209.99x |
| Price / SalesMarket cap ÷ Revenue | 3.48x | 6.96x |
| Price / BookPrice ÷ Book value/share | 32.04x | 7.48x |
| Price / FCFMarket cap ÷ FCF | 231.45x | 37.29x |
Profitability & Efficiency
AFRM leads this category, winning 5 of 8 comparable metrics.
Profitability & Efficiency
AFRM delivers a 11.2% return on equity — every $100 of shareholder capital generates $11 in annual profit, vs $-68 for CHYM. CHYM carries lower financial leverage with a 0.10x debt-to-equity ratio, signaling a more conservative balance sheet compared to AFRM's 2.56x. On the Piotroski fundamental quality scale (0–9), AFRM scores 6/9 vs CHYM's 3/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -67.9% | +11.2% |
| ROA (TTM)Return on assets | -49.8% | +3.1% |
| ROICReturn on invested capital | -60.2% | -0.7% |
| ROCEReturn on capital employed | -78.1% | -0.9% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 6 |
| Debt / EquityFinancial leverage | 0.10x | 2.56x |
| Net DebtTotal debt minus cash | -$332M | $6.5B |
| Cash & Equiv.Liquid assets | $466M | $1.4B |
| Total DebtShort + long-term debt | $135M | $7.9B |
| Interest CoverageEBIT ÷ Interest expense | — | 1.88x |
Total Returns (Dividends Reinvested)
AFRM leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in AFRM five years ago would be worth $12,474 today (with dividends reinvested), compared to $5,123 for CHYM. Over the past 12 months, AFRM leads with a +30.7% total return vs CHYM's -48.8%. The 3-year compound annual growth rate (CAGR) favors AFRM at 78.0% vs CHYM's -20.0% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -28.0% | -9.0% |
| 1-Year ReturnPast 12 months | -48.8% | +30.7% |
| 3-Year ReturnCumulative with dividends | -48.8% | +464.2% |
| 5-Year ReturnCumulative with dividends | -48.8% | +24.7% |
| 10-Year ReturnCumulative with dividends | -48.8% | -30.7% |
| CAGR (3Y)Annualised 3-year return | -20.0% | +78.0% |
Risk & Volatility
Evenly matched — CHYM and AFRM each lead in 1 of 2 comparable metrics.
Risk & Volatility
CHYM is the less volatile stock with a 2.50 beta — it tends to amplify market swings less than AFRM's 2.72 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. AFRM currently trades 67.4% from its 52-week high vs CHYM's 42.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.50x | 2.72x |
| 52-Week HighHighest price in past year | $44.94 | $100.00 |
| 52-Week LowLowest price in past year | $16.17 | $42.09 |
| % of 52W HighCurrent price vs 52-week peak | +42.3% | +67.4% |
| RSI (14)Momentum oscillator 0–100 | 50.6 | 63.1 |
| Avg Volume (50D)Average daily shares traded | 4.7M | 5.3M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates CHYM as "Buy" and AFRM as "Buy". Consensus price targets imply 39.4% upside for CHYM (target: $27) vs 19.9% for AFRM (target: $81).
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $26.50 | $80.77 |
| # AnalystsCovering analysts | 8 | 33 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | — | — |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +1.0% | +1.1% |
AFRM leads in 4 of 6 categories — strongest in Income & Cash Flow and Valuation Metrics. 1 category is tied.
CHYM vs AFRM: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is CHYM or AFRM a better buy right now?
For growth investors, Affirm Holdings, Inc.
(AFRM) is the stronger pick with 38. 8% revenue growth year-over-year, versus 30. 7% for Chime Financial, Inc. Class A Common Stock (CHYM). Affirm Holdings, Inc. (AFRM) offers the better valuation at 449. 1x trailing P/E (62. 5x forward), making it the more compelling value choice. Analysts rate Chime Financial, Inc. Class A Common Stock (CHYM) a "Buy" — based on 8 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CHYM or AFRM?
On forward P/E, Affirm Holdings, Inc.
is actually cheaper at 62. 5x.
03Which is the better long-term investment — CHYM or AFRM?
Over the past 5 years, Affirm Holdings, Inc.
(AFRM) delivered a total return of +24. 7%, compared to -48. 8% for Chime Financial, Inc. Class A Common Stock (CHYM). Over 10 years, the gap is even starker: AFRM returned -30. 7% versus CHYM's -48. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CHYM or AFRM?
By beta (market sensitivity over 5 years), Chime Financial, Inc.
Class A Common Stock (CHYM) is the lower-risk stock at 2. 50β versus Affirm Holdings, Inc. 's 2. 72β — meaning AFRM is approximately 9% more volatile than CHYM relative to the S&P 500. On balance sheet safety, Chime Financial, Inc. Class A Common Stock (CHYM) carries a lower debt/equity ratio of 10% versus 3% for Affirm Holdings, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — CHYM or AFRM?
By revenue growth (latest reported year), Affirm Holdings, Inc.
(AFRM) is pulling ahead at 38. 8% versus 30. 7% for Chime Financial, Inc. Class A Common Stock (CHYM). On earnings-per-share growth, the picture is similar: Affirm Holdings, Inc. grew EPS 109. 0% year-over-year, compared to -37. 2% for Chime Financial, Inc. Class A Common Stock. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CHYM or AFRM?
Affirm Holdings, Inc.
(AFRM) is the more profitable company, earning 1. 6% net margin versus -46. 2% for Chime Financial, Inc. Class A Common Stock — meaning it keeps 1. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AFRM leads at -2. 7% versus -47. 6% for CHYM. At the gross margin level — before operating expenses — CHYM leads at 85. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CHYM or AFRM more undervalued right now?
On forward earnings alone, Affirm Holdings, Inc.
(AFRM) trades at 62. 5x forward P/E versus 112. 9x for Chime Financial, Inc. Class A Common Stock — 50. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CHYM: 39. 4% to $26. 50.
08Which pays a better dividend — CHYM or AFRM?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is CHYM or AFRM better for a retirement portfolio?
For long-horizon retirement investors, Affirm Holdings, Inc.
(AFRM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding. Chime Financial, Inc. Class A Common Stock (CHYM) carries a higher beta of 2. 50 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (AFRM: -30. 7%, CHYM: -48. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CHYM and AFRM?
These companies operate in different sectors (CHYM (Financial Services) and AFRM (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.